Other Species / Isoforms
  mTOR (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K42-ub
ETRAKAAkELQHYVT
0 1
mTOR (human) ETRAKAAkELQHYVT K42-ub
mTOR (mouse) ETRAKAAKELQHYVT K42
mTOR (rat) ETRAKAAKELQHYVT K42
K84-ub
SSDANERkGGILAIA
0 1
mTOR (human) SSDANERkGGILAIA K84-ub
mTOR (mouse) SSDANERKGGILAIA K84
mTOR (rat) SSDANERKGGILAIA K84
S92-p
GGILAIAsLIGVEGG
0 1
mTOR (human) GGILAIAsLIGVEGG S92-p
mTOR (mouse) GGILAIASLIGVEGG S92
mTOR (rat) GGILAIASLIGVEGG S92
T102-p
GVEGGNAtRIGRFAN
0 1
mTOR (human) GVEGGNAtRIGRFAN T102-p
mTOR (mouse) GVEGGNSTRIGRFAN T102
mTOR (rat) GVEGGNSTRIGRFAN T102
Y110-p
RIGRFANyLRNLLPS
0 3
mTOR (human) RIGRFANyLRNLLPS Y110-p
mTOR (mouse) RIGRFANYLRNLLPS Y110
mTOR (rat) RIGRFANYLRNLLPS Y110
K128-ub
VVMEMASkAIGRLAM
0 1
mTOR (human) VVMEMASkAIGRLAM K128-ub
mTOR (mouse) VVMEMASKAIGRLAM K128
mTOR (rat) VVMEMASKAIGRLAM K128
K230-ub
REPKEMQkPQWYRHT
0 2
mTOR (human) REPKEMQkPQWYRHT K230-ub
mTOR (mouse) REPKEMQkPQWYRHT K230-ub
mTOR (rat) REPKEMQKPQWYRHT K230
K230
REPKEMQKPQWYRHT
0 1
mTOR (human) REPKEMQKPQWYRHT K230
mTOR (mouse) REPKEMQKPQWYRHT K230
mTOR (rat) REPKEMQkPQWYRHT K230-ac
K243-ub
HTFEEAEkGFDETLA
0 3
mTOR (human) HTFEEAEkGFDETLA K243-ub
mTOR (mouse) HTFEEAEkGFDETLA K243-ub
mTOR (rat) HTFEEAEKGFDETLA K243
K251-ub
GFDETLAkEKGMNRD
0 2
mTOR (human) GFDETLAkEKGMNRD K251-ub
mTOR (mouse) GFDETLAKEKGMNRD K251
mTOR (rat) GFDETLAKEKGMNRD K251
K298-ub
QQQLVHDkYCkDLMG
0 2
mTOR (human) QQQLVHDkYCkDLMG K298-ub
mTOR (mouse) QQQLVHDkYCKDLMG K298-ub
mTOR (rat) QQQLVHDKYCKDLMG K298
K301-ub
LVHDkYCkDLMGFGt
0 2
mTOR (human) LVHDkYCkDLMGFGt K301-ub
mTOR (mouse) LVHDkYCKDLMGFGT K301
mTOR (rat) LVHDKYCKDLMGFGT K301
T308-p
kDLMGFGtkPRHItP
0 1
mTOR (human) kDLMGFGtkPRHItP T308-p
mTOR (mouse) KDLMGFGTKPRHITP T308
mTOR (rat) KDLMGFGTKPRHITP T308
K309-ub
DLMGFGtkPRHItPF
0 3
mTOR (human) DLMGFGtkPRHItPF K309-ub
mTOR (mouse) DLMGFGTKPRHITPF K309
mTOR (rat) DLMGFGTKPRHITPF K309
T314-p
GtkPRHItPFTSFQA
0 1
mTOR (human) GtkPRHItPFTSFQA T314-p
mTOR (mouse) GTKPRHITPFTSFQA T314
mTOR (rat) GTKPRHITPFTSFQA T314
K369-ub
CRDLMEEkFDQVCQW
0 2
mTOR (human) CRDLMEEkFDQVCQW K369-ub
mTOR (mouse) CRDLMEEKFDQVCQW K369
mTOR (rat) CRDLMEEKFDQVCQW K369
K379-ub
QVCQWVLkCRNSkNS
0 1
mTOR (human) QVCQWVLkCRNSkNS K379-ub
mTOR (mouse) QVCQWVLKCRSSKNS K379
mTOR (rat) QVCQWVLKCRSSKNS K379
K384-ub
VLkCRNSkNSLIQMT
0 1
mTOR (human) VLkCRNSkNSLIQMT K384-ub
mTOR (mouse) VLKCRSSKNSLIQMT K384
mTOR (rat) VLKCRSSKNSLIQMT K384
K449-ub
VAVRSEFkVYLPRVL
0 1
mTOR (human) VAVRSEFkVYLPRVL K449-ub
mTOR (mouse) VAVRSEFKVYLPRVL K449
mTOR (rat) VAVRSEFKVYLPRVL K449
K533-ub
RQIPQLKkDIQDGLL
0 1
mTOR (human) RQIPQLKkDIQDGLL K533-ub
mTOR (mouse) RQIPQLKKDIQDGLL K533
mTOR (rat) RQIPQLKKDIQDGLL K533
S567-p
GLAHQLAsPGLTTLP
Upstream
0 8
Treatment
  • nocodazole
mTOR (human) GLAHQLAsPGLTTLP S567-p
mTOR (mouse) GLAHQLASPGLTTLP S567
mTOR (rat) GLAHQLASPGLTTLP S567
K616-ub
HFLNSEHkEIRMEAA
0 1
mTOR (human) HFLNSEHkEIRMEAA K616-ub
mTOR (mouse) HFLNSEHKEIRMEAA K616
mTOR (rat) HFLNSEHKEIRMEAA K616
T631-p
RTCSRLLtPSIHLIS
Upstream
Downstream
1 0
Effects on Modified Protein
  • protein degradation
  • ubiquitination
Regulatory protein:
  • DYRK2 (human)
mTOR (human) RTCSRLLtPSIHLIS T631-p
mTOR (mouse) RTCSRLLTPSIHLIS T631
mTOR (rat) RTCSRLLTPSIHLIS T631
T665-p
KLLVVGItDPDPDIR
0 1
mTOR (human) KLLVVGItDPDPDIR T665-p
mTOR (mouse) KLLVVGITDPDPDIR T665
mTOR (rat) KLLVVGITDPDPDIR T665
S719-p
ICTVGRLsSMNPAFV
0 1
mTOR (human) ICTVGRLsSMNPAFV S719-p
mTOR (mouse) ICTVGRLSSMNPAFV S719
mTOR (rat) ICTVGRLSSMNPAFV S719
K777-ub
PYMEPILkALILKLK
0 1
mTOR (human) PYMEPILkALILKLK K777-ub
mTOR (mouse) PYMEPILKALILKLK K777
mTOR (rat) PYMEPILKALILKLK K777
Y858
TGYVVEPYRKyPTLL
0 1
mTOR (human) TGYVVEPYRKyPTLL Y858
mTOR (mouse) TGYVVEPyRKyPTLL Y858-p
mTOR (rat) TGYVVEPYRKYPTLL Y858
Y861-p
VVEPYRKyPTLLEVL
0 1
mTOR (human) VVEPYRKyPTLLEVL Y861-p
mTOR (mouse) VVEPyRKyPTLLEVL Y861-p
mTOR (rat) VVEPYRKYPTLLEVL Y861
T880-p
KTEQNQGtRREAIRV
0 1
mTOR (human) KTEQNQGtRREAIRV T880-p
mTOR (mouse) KTEQNQGtRREAIRV T880-p
mTOR (rat) KTEQNQGTRREAIRV T880
K898-ub
LGALDPYkHkVNIGM
0 3
mTOR (human) LGALDPYkHkVNIGM K898-ub
mTOR (mouse) LGALDPYkHkVNIGM K898-ub
mTOR (rat) LGALDPYKHKVNIGM K898
K900-ub
ALDPYkHkVNIGMID
0 5
mTOR (human) ALDPYkHkVNIGMID K900-ub
mTOR (mouse) ALDPYkHkVNIGMID K900-ub
mTOR (rat) ALDPYKHKVNIGMID K900
S909-p
NIGMIDQsRDASAVs
0 1
mTOR (human) NIGMIDQsRDASAVs S909-p
mTOR (mouse) NIGMIDQSRDASAVS S909
mTOR (rat) NIGMIDQSRDASAVS S909
S916-p
sRDASAVsLsESKSS
0 1
mTOR (human) sRDASAVsLsESKSS S916-p
mTOR (mouse) SRDASAVSLSESKSS S916
mTOR (rat) SRDASAVSLSESKSS S916
S918-p
DASAVsLsESKSSQD
0 1
mTOR (human) DASAVsLsESKSSQD S918-p
mTOR (mouse) DASAVSLSESKSSQD S918
mTOR (rat) DASAVSLSESKSSQD S918
S1131-p
APEAPLPsRkAALET
0 1
mTOR (human) APEAPLPsRkAALET S1131-p
mTOR (mouse) APEVPLPSRKAALET S1131
mTOR (rat) APEVPLPSRKAALET S1131
K1133-ub
EAPLPsRkAALETVD
0 2
mTOR (human) EAPLPsRkAALETVD K1133-ub
mTOR (mouse) EVPLPSRKAALETVD K1133
mTOR (rat) EVPLPSRKAALETVD K1133
T1162-p
IIHPIVRtLDQsPEL
Upstream
0 13
Treatment
  • EGF
  • MG132_withdrawal
  • nocodazole
  • SB202190
  • U0126
mTOR (human) IIHPIVRtLDQsPEL T1162-p
mTOR (mouse) IIHPIVRtLDQSPEL T1162-p
mTOR (rat) IIHPIVRTLDQSPEL T1162
S1166-p
IVRtLDQsPELRstA
Upstream
0 3
Treatment
  • EGF
  • nocodazole
  • SB202190
mTOR (human) IVRtLDQsPELRstA S1166-p
mTOR (mouse) IVRtLDQSPELRSTA S1166
mTOR (rat) IVRTLDQSPELRSTA S1166
S1171-p
DQsPELRstAMDTLS
0 2
mTOR (human) DQsPELRstAMDTLS S1171-p
mTOR (mouse) DQSPELRSTAMDTLS S1171
mTOR (rat) DQSPELRSTAMDTLS S1171
T1172-p
QsPELRstAMDTLSS
0 2
mTOR (human) QsPELRstAMDTLSS T1172-p
mTOR (mouse) QSPELRSTAMDTLSS T1172
mTOR (rat) QSPELRSTAMDTLSS T1172
K1187-ub
LVFQLGKkyQIFIPM
0 1
mTOR (human) LVFQLGKkyQIFIPM K1187-ub
mTOR (mouse) LVFQLGKKYQIFIPM K1187
mTOR (rat) LVFQLGKKYQIFIPM K1187
Y1188-p
VFQLGKkyQIFIPMV
0 1
mTOR (human) VFQLGKkyQIFIPMV Y1188-p
mTOR (mouse) VFQLGKKYQIFIPMV Y1188
mTOR (rat) VFQLGKKYQIFIPMV Y1188
K1197-ub
IFIPMVNkVLVRHRI
0 1
mTOR (human) IFIPMVNkVLVRHRI K1197-ub
mTOR (mouse) IFIPMVNKVLVRHRI K1197
mTOR (rat) IFIPMVNKVLVRHRI K1197
K1218-ac
VLICRIVkGYTLADE
0 5
mTOR (human) VLICRIVkGYTLADE K1218-ac
mTOR (mouse) VLICRIVKGYTLADE K1218
mTOR (rat) VLICRIVkGYTLADE K1218-ac
K1218-ub
VLICRIVkGYTLADE
0 4
mTOR (human) VLICRIVkGYTLADE K1218-ub
mTOR (mouse) VLICRIVkGYTLADE K1218-ub
mTOR (rat) VLICRIVKGYTLADE K1218
Y1232-p
EEEDPLIyQHRMLRS
0 16
mTOR (human) EEEDPLIyQHRMLRS Y1232-p
mTOR (mouse) EEEDPLIYQHRMLRS Y1232
mTOR (rat) EEEDPLIYQHRMLRS Y1232
K1256-ac
PVETGPMkkLHVstI
0 1
mTOR (human) PVETGPMkkLHVstI K1256-ac
mTOR (mouse) PVETGPMKkLHVstI K1256
mTOR (rat) PVETGPMKKLHVsTI K1256
K1256-ub
PVETGPMkkLHVstI
0 3
mTOR (human) PVETGPMkkLHVstI K1256-ub
mTOR (mouse) PVETGPMkkLHVstI K1256-ub
mTOR (rat) PVETGPMKKLHVsTI K1256
K1257-ub
VETGPMkkLHVstIN
0 4
mTOR (human) VETGPMkkLHVstIN K1257-ub
mTOR (mouse) VETGPMkkLHVstIN K1257-ub
mTOR (rat) VETGPMKKLHVsTIN K1257
S1261-p
PMkkLHVstINLQkA
Upstream
Downstream
2 32
Effects on Modified Protein
  • phosphorylation
Effects on Biological Processes:
  • cell growth, induced
  • signaling pathway regulation
Treatment
  • amino_acid_starvation
  • amino_acids
  • insulin
  • ischemia
  • MLN8054
  • rapamycin
  • wortmannin
mTOR (human) PMkkLHVstINLQkA S1261-p
mTOR (mouse) PMkkLHVstINLQKA S1261-p
mTOR (rat) PMKKLHVsTINLQKA S1261-p
T1262-p
MkkLHVstINLQkAW
0 2
mTOR (human) MkkLHVstINLQkAW T1262-p
mTOR (mouse) MkkLHVstINLQKAW T1262-p
mTOR (rat) MKKLHVsTINLQKAW T1262
K1267-ub
VstINLQkAWGAARR
0 1
mTOR (human) VstINLQkAWGAARR K1267-ub
mTOR (mouse) VstINLQKAWGAARR K1267
mTOR (rat) VsTINLQKAWGAARR K1267
S1288-p
LEWLRRLsLELLkDS
0 1
mTOR (human) LEWLRRLsLELLkDS S1288-p
mTOR (mouse) LEWLRRLSLELLkDS S1288
mTOR (rat) LEWLRRLSLELLKDS S1288
K1293-ub
RLsLELLkDSSsPsL
0 4
mTOR (human) RLsLELLkDSSsPsL K1293-ub
mTOR (mouse) RLSLELLkDSSSPSL K1293-ub
mTOR (rat) RLSLELLKDSSSPSL K1293
S1297-p
ELLkDSSsPsLRSCW
0 1
mTOR (human) ELLkDSSsPsLRSCW S1297-p
mTOR (mouse) ELLkDSSSPSLRSCW S1297
mTOR (rat) ELLKDSSSPSLRSCW S1297
S1299-p
LkDSSsPsLRSCWAL
0 1
mTOR (human) LkDSSsPsLRSCWAL S1299-p
mTOR (mouse) LkDSSSPSLRSCWAL S1299
mTOR (rat) LKDSSSPSLRSCWAL S1299
K1395-ub
AKCRAYAkALHYkEL
0 2
mTOR (human) AKCRAYAkALHYkEL K1395-ub
mTOR (mouse) AKCRAYAKALHYkEL K1395
mTOR (rat) AKCRAYAKALHYKEL K1395
K1400-ub
YAkALHYkELEFQkG
0 4
mTOR (human) YAkALHYkELEFQkG K1400-ub
mTOR (mouse) YAKALHYkELEFQkG K1400-ub
mTOR (rat) YAKALHYKELEFQKG K1400
K1406-ub
YkELEFQkGPTPAIL
0 5
mTOR (human) YkELEFQkGPTPAIL K1406-ub
mTOR (mouse) YkELEFQkGPTPAIL K1406-ub
mTOR (rat) YKELEFQKGPTPAIL K1406
S1415-p
PTPAILEsLIsINNK
Upstream
Downstream
1 1
Effects on Modified Protein
  • enzymatic activity, induced
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell growth, induced
Kinase, in vitro:
  • IKKA (human)
Putative in vivo kinases:
  • IKKA (human)
Regulatory protein:
  • Akt1 (human)
  • Akt2 (human)
  • PTEN (human)
Treatment
  • insulin
  • siRNA
mTOR (human) PTPAILEsLIsINNK S1415-p
mTOR (mouse) PTPAILESLIsINNK S1415
mTOR (rat) PTPAILESLISINNK S1415
S1418-p
AILEsLIsINNKLQQ
Upstream
1 6
Kinase, in vitro:
  • IKKA (human)
mTOR (human) AILEsLIsINNKLQQ S1418-p
mTOR (mouse) AILESLIsINNKLQQ S1418-p
mTOR (rat) AILESLISINNKLQQ S1418
K1465-ub
DALVAYDkKMDTNkD
0 2
mTOR (human) DALVAYDkKMDTNkD K1465-ub
mTOR (mouse) DALVAYDkKMDTNkE K1465-ub
mTOR (rat) DALVAYDKKMDTNKD K1465
K1471-ub
DkKMDTNkDDPELML
0 2
mTOR (human) DkKMDTNkDDPELML K1471-ub
mTOR (mouse) DkKMDTNkEDPELML K1471-ub
mTOR (rat) DKKMDTNKDDPELML K1471
K1500-ub
LHQQCCEkWtLVNDE
0 1
mTOR (human) LHQQCCEkWtLVNDE K1500-ub
mTOR (mouse) LHQQCCEKWTLVNDE K1500
mTOR (rat) LHQQCCEKWTLVNDE K1500
T1502-p
QQCCEkWtLVNDETQ
0 1
mTOR (human) QQCCEkWtLVNDETQ T1502-p
mTOR (mouse) QQCCEKWTLVNDETQ T1502
mTOR (rat) QQCCEKWTLVNDETQ T1502
K1511-ub
VNDETQAkMARMAAA
0 2
mTOR (human) VNDETQAkMARMAAA K1511-ub
mTOR (mouse) VNDETQAkMARMAAA K1511-ub
mTOR (rat) VNDETQAKMARMAAA K1511
K1566-ub
LAQQCIDkARDLLDA
0 1
mTOR (human) LAQQCIDkARDLLDA K1566-ub
mTOR (mouse) LAQQCIDKARDLLDA K1566
mTOR (rat) LAQQCIDKARDLLDA K1566
K1635-ub
RIVEDWQkILMVRSL
0 1
mTOR (human) RIVEDWQkILMVRSL K1635-ub
mTOR (mouse) RIVEDWQKILMVRSL K1635
mTOR (rat) RIVEDWQKILMVRSL K1635
K1655-ub
EDMRTWLkYASLCGk
0 3
mTOR (human) EDMRTWLkYASLCGk K1655-ub
mTOR (mouse) EDMRTWLkYASLCGK K1655-ub
mTOR (rat) EDMRTWLKyASLCGK K1655
Y1656
DMRTWLkYASLCGkS
0 12
mTOR (human) DMRTWLkYASLCGkS Y1656
mTOR (mouse) DMRTWLkYASLCGKS Y1656
mTOR (rat) DMRTWLKyASLCGKS Y1656-p
K1662-ub
kYASLCGkSGRLALA
0 2
mTOR (human) kYASLCGkSGRLALA K1662-ub
mTOR (mouse) kYASLCGKSGRLALA K1662
mTOR (rat) KyASLCGKSGRLALA K1662
K1745-ub
QHKQELHkLMARCFL
0 1
mTOR (human) QHKQELHkLMARCFL K1745-ub
mTOR (mouse) QHKQELHKLMARCFL K1745
mTOR (rat) QHKQELHKLMARCFL K1745
Y1804-p
NFEAVLHyKHQNQAR
0 1
mTOR (human) NFEAVLHyKHQNQAR Y1804-p
mTOR (mouse) NFEAVLHYKHQNQAR Y1804
mTOR (rat) NFEAVLHYKHQNQAR Y1804
S1821-p
KKKLRHAsGANITNA
0 2
mTOR (human) KKKLRHAsGANITNA S1821-p
mTOR (mouse) KKKLRHASGANITNA S1821
mTOR (rat) KKKLRHASGANITNA S1821
S1859-p
EAESTENsPTPSPLQ
0 1
mTOR (human) EAESTENsPTPSPLQ S1859-p
mTOR (mouse) EAESNENSPTPSPLQ S1859
mTOR (rat) EAESNESSPTPSPLQ S1859
T1870-p
SPLQKKVtEDLsKtL
0 2
mTOR (human) SPLQKKVtEDLsKtL T1870-p
mTOR (mouse) SPLQKKVTEDLSKTL T1870
mTOR (rat) SPLQKKVTEDLSKTL T1870
S1874-p
KKVtEDLsKtLLMyT
0 1
mTOR (human) KKVtEDLsKtLLMyT S1874-p
mTOR (mouse) KKVTEDLSKTLLLYT S1874
mTOR (rat) KKVTEDLSKTLLLYT S1874
T1876-p
VtEDLsKtLLMyTVP
0 1
mTOR (human) VtEDLsKtLLMyTVP T1876-p
mTOR (mouse) VTEDLSKTLLLYTVP T1876
mTOR (rat) VTEDLSKTLLLYTVP T1876
Y1880-p
LsKtLLMyTVPAVQG
0 1
mTOR (human) LsKtLLMyTVPAVQG Y1880-p
mTOR (mouse) LSKTLLLYTVPAVQG Y1880
mTOR (rat) LSKTLLLYTVPAVQG Y1880
S1893-p
QGFFRSIsLSRGNNL
Upstream
0 2
Treatment
  • ischemia
mTOR (human) QGFFRSIsLSRGNNL S1893-p
mTOR (mouse) QGFFRSISLSRGNNL S1893
mTOR (rat) QGFFRSISLSRGNNL S1893
T1948-p
QLIARIDtPRPLVGR
0 1
mTOR (human) QLIARIDtPRPLVGR T1948-p
mTOR (mouse) QLIARIDTPRPLVGR T1948
mTOR (rat) QLIARIDTPRPLVGR T1948
K1993-ub
ARHNAANkILKNMCE
0 1
mTOR (human) ARHNAANkILKNMCE K1993-ub
mTOR (mouse) ARHNAANKILKNMCE K1993
mTOR (rat) ARHNAANKILKNMCE K1993
K2045-ub
YFGERNVkGMFEVLE
0 1
mTOR (human) YFGERNVkGMFEVLE K2045-ub
mTOR (mouse) YFGERNVKGMFEVLE K2045
mTOR (rat) YFGERNVKGMFEVLE K2045
K2066-ub
ERGPQTLkETsFNQA
0 4
mTOR (human) ERGPQTLkETsFNQA K2066-ub
mTOR (mouse) ERGPQTLkETsFNQA K2066-ub
mTOR (rat) ERGPQTLKETSFNQA K2066
S2069-p
PQTLkETsFNQAYGR
0 2
mTOR (human) PQTLkETsFNQAYGR S2069-p
mTOR (mouse) PQTLkETsFNQAYGR S2069-p
mTOR (rat) PQTLKETSFNQAYGR S2069
S2155-p
QPIIRIQsIAPsLQV
0 1
mTOR (human) QPIIRIQsIAPsLQV S2155-p
mTOR (mouse) QPIIRIQSIAPSLQV S2155
mTOR (rat) QPIIRIQSIAPSLQV S2155
S2159-p
RIQsIAPsLQVItSk
Upstream
Downstream
2 2
Effects on Modified Protein
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • cell cycle regulation
  • cell growth, induced
  • signaling pathway regulation
Treatment
  • staurosporine
  • Torin1
mTOR (human) RIQsIAPsLQVItSk S2159-p
mTOR (mouse) RIQSIAPSLQVITSK S2159
mTOR (rat) RIQSIAPSLQVITSK S2159
T2164-p
APsLQVItSkQRPRK
Upstream
Downstream
1 1
Effects on Modified Protein
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • cell cycle regulation
  • cell growth, induced
  • signaling pathway regulation
Treatment
  • staurosporine
  • Torin1
mTOR (human) APsLQVItSkQRPRK T2164-p
mTOR (mouse) APSLQVITSKQRPRK T2164
mTOR (rat) APSLQVITSKQRPRK T2164
K2166-ub
sLQVItSkQRPRKLT
0 2
mTOR (human) sLQVItSkQRPRKLT K2166-ub
mTOR (mouse) SLQVITSKQRPRKLT K2166
mTOR (rat) SLQVITSKQRPRKLT K2166
K2218-ub
NDPTSLRkNLSIQRY
0 1
mTOR (human) NDPTSLRkNLSIQRY K2218-ub
mTOR (mouse) NDPTSLRKNLSIQRY K2218
mTOR (rat) NDPTSLRKNLSIQRY K2218
K2301-ub
TAGDDLAkLLWLKSP
0 1
mTOR (human) TAGDDLAkLLWLKSP K2301-ub
mTOR (mouse) TAGDDLAKLLWLKSP K2301
mTOR (rat) TAGDDLAKLLWLKSP K2301
K2370-ub
EVAMTREkFPEKIPF
0 3
mTOR (human) EVAMTREkFPEKIPF K2370-ub
mTOR (mouse) EVAMTREkFPEKIPF K2370-ub
mTOR (rat) EVAMTREKFPEKIPF K2370
T2380-p
EKIPFRLtRMLTNAM
0 1
mTOR (human) EKIPFRLtRMLTNAM T2380-p
mTOR (mouse) EKIPFRLTRMLTNAM T2380
mTOR (rat) EKIPFRLTRMLTNAM T2380
T2434-p
LNWRLMDtNtKGNKR
0 1
mTOR (human) LNWRLMDtNtKGNKR T2434-p
mTOR (mouse) LNWRLMDTNTKGNKR T2434
mTOR (rat) LNWRLMDTNAKGNKR T2434
T2436-p
WRLMDtNtKGNKRsR
0 1
mTOR (human) WRLMDtNtKGNKRsR T2436-p
mTOR (mouse) WRLMDTNTKGNKRsR T2436
mTOR (rat) WRLMDTNAKGNKRSR A2436
S2442-p
NtKGNKRsRtRtDsy
0 3
mTOR (human) NtKGNKRsRtRtDsy S2442-p
mTOR (mouse) NTKGNKRsRtRtDsy S2442-p
mTOR (rat) NAKGNKRSRTRTDsY S2442
T2444-p
KGNKRsRtRtDsysA
Upstream
0 13
Treatment
  • gefitinib
mTOR (human) KGNKRsRtRtDsysA T2444-p
mTOR (mouse) KGNKRsRtRtDsysA T2444-p
mTOR (rat) KGNKRSRTRTDsYSA T2444
T2446-p
NKRsRtRtDsysAGQ
Upstream
4 16
Kinase, in vitro:
  • Akt1 (human)
  • p70S6K (human)
Putative in vivo kinases:
  • p70S6K (human)
Treatment
  • gefitinib
  • insulin
  • phorbol_ester
  • rapamycin
  • wortmannin
mTOR (human) NKRsRtRtDsysAGQ T2446-p
mTOR (mouse) NKRsRtRtDsysAGQ T2446-p
mTOR (rat) NKRSRTRTDsYSAGQ T2446
S2448-p
RsRtRtDsysAGQsV
Upstream
Downstream
128 122
mTOR (human)
S2448-p
mTOR (mouse)
S2448-p
mTOR (rat)
S2448-p
Effects on Modified Protein
  • enzymatic activity, induced
  • intracellular localization
  • phosphorylation
Effects on Biological Processes:
  • autophagy, inhibited
  • carcinogenesis, induced
  • cell growth, induced
  • signaling pathway regulation
Kinase, in vitro:
  • Akt1 (human)
  • p70S6K (human)
Putative in vivo kinases:
  • Akt1 (human)
  • p70S6K (human)
Regulatory protein:
  • Akt1 (cow)
  • Akt1 (human)
  • AMPKA1 (human)
  • CIP2A (human)
  • DUSP6 (human)
  • FAK (human)
  • GRP78 (human)
  • IL24 (human)
  • mTOR (human)
  • Notch 1 (human)
  • NuaK1 (human)
  • p53 (human)
  • PDCD6 (human)
  • PHLPP (human)
  • PHLPP2 (human)
  • RAF1 (human)
  • Raptor (human)
  • RICTOR (human)
Treatment
  • acadesine
  • afatinib
  • Akt-I-1
  • aloe-emodin
  • amino_acid_starvation
  • amino_acids
  • anti-HLA
  • As2O3
  • AZD8055
  • bicyclol
  • Cbz-B3A
  • colforsin
  • collagen XIX (NC1 domain)
  • compound_C
  • cycloheximide
  • DMSO
  • exercise
  • fasting
  • GDNF
  • gefitinib
  • GSK2334470
  • heregulin
  • HGF
  • IFN-beta
  • IFN-gamma
  • IGF-1
  • IL-24
  • IL-3
  • imatinib
  • insulin
  • JQ1
  • L-glutamine_withdrawal
  • laminar flow
  • liothyronine
  • LLL12
  • LPS
  • LY294002
  • metformin
  • methyl-beta-cyclodextrin
  • MHY1485
  • nocodazole
  • oscillatory_flow
  • OSI-027
  • osteopontin
  • OSU-03012
  • ouabain
  • pemetrexed
  • phorbol_ester
  • pimenta doica
  • PP2
  • PP242
  • pravastatin
  • QLT0267
  • RAD001
  • rapamycin
  • resveratrol
  • retinoic_acid
  • RGD
  • SB202190
  • SB203580
  • SB216763
  • selenite
  • serum
  • sildenafil
  • siRNA
  • sorafenib
  • Su11274
  • SU6656
  • sunitinib
  • triptolide
  • tunicamycin
  • U0126
  • UV
  • VEGF
  • virus infection
  • wortmannin
mTOR (human) RsRtRtDsysAGQsV S2448-p
mTOR (mouse) RsRtRtDsysAGQsV S2448-p
mTOR (rat) RSRTRTDsYSAGQSV S2448-p
Y2449-p
sRtRtDsysAGQsVE
Upstream
0 46
Treatment
  • gefitinib
  • Su11274
mTOR (human) sRtRtDsysAGQsVE Y2449-p
mTOR (mouse) sRtRtDsysAGQsVE Y2449-p
mTOR (rat) SRTRTDsYSAGQSVE Y2449
S2450-p
RtRtDsysAGQsVEI
Upstream
0 35
Treatment
  • gefitinib
  • imatinib
mTOR (human) RtRtDsysAGQsVEI S2450-p
mTOR (mouse) RtRtDsysAGQsVEI S2450-p
mTOR (rat) RTRTDsYSAGQSVEI S2450
S2454-p
DsysAGQsVEILDGV
Upstream
0 55
Kinase, in vitro:
  • mTOR (human)
Treatment
  • gefitinib
  • imatinib
  • Su11274
mTOR (human) DsysAGQsVEILDGV S2454-p
mTOR (mouse) DsysAGQsVEILDGV S2454-p
mTOR (rat) DsYSAGQSVEILDGV S2454
T2471-p
GEPAHKKtGttVPEs
0 1
mTOR (human) GEPAHKKtGttVPEs T2471-p
mTOR (mouse) GEPAHKKAGttVPEs A2471
mTOR (rat) GEPAHKKTGTTVPEs T2471
T2473-p
PAHKKtGttVPEsIH
Upstream
0 4
Kinase, in vitro:
  • mTOR (human)
mTOR (human) PAHKKtGttVPEsIH T2473-p
mTOR (mouse) PAHKKAGttVPEsIH T2473-p
mTOR (rat) PAHKKTGTTVPEsIH T2473
T2474-p
AHKKtGttVPEsIHs
Upstream
0 7
Kinase, in vitro:
  • mTOR (human)
mTOR (human) AHKKtGttVPEsIHs T2474-p
mTOR (mouse) AHKKAGttVPEsIHs T2474-p
mTOR (rat) AHKKTGTTVPEsIHs T2474
S2478-p
tGttVPEsIHsFIGD
Upstream
0 24
Kinase, in vitro:
  • mTOR (human)
mTOR (human) tGttVPEsIHsFIGD S2478-p
mTOR (mouse) AGttVPEsIHsFIGD S2478-p
mTOR (rat) TGTTVPEsIHsFIGD S2478-p
S2481-p
tVPEsIHsFIGDGLV
Upstream
Downstream
52 29
mTOR (human)
S2481-p
mTOR (mouse)
S2481-p
mTOR (rat)
S2481-p
Effects on Modified Protein
  • enzymatic activity, induced
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • mTOR (human)
Putative in vivo kinases:
  • mTOR (human)
Regulatory protein:
  • DYRK2 (human)
  • HRas (human)
  • ILK (human)
  • mTOR (human)
  • Notch 1 (human)
  • p53 (human)
  • PIK3C2A (human)
  • PIK3CB (human)
  • PIP3-E (human)
  • Raptor (human)
  • RHEB (human)
  • RICTOR (human)
  • Sin1 (human)
  • TBK1 (human)
  • ULK1 (human)
Treatment
  • 2-deoxyglucose
  • 5-HT
  • amino_acid_starvation
  • amino_acids
  • angiotensin_2
  • anisomycin
  • AZD8055
  • calyculin_A
  • Cbz-B3A
  • celastrol
  • collagen XIX (NC1 domain)
  • EGF
  • GSK2334470
  • histidinol
  • IFN-gamma
  • IGF-1
  • IL-6
  • imatinib
  • insulin
  • ionizing_radiation
  • KU-0063794
  • LPS
  • LY294002
  • ML120B
  • OSI-027
  • pemetrexed
  • phorbol_ester
  • PP242
  • rapamycin
  • selenite
  • serum
  • serum_withdrawal
  • sildenafil
  • siRNA
  • SP600125
  • staurosporine
  • sunitinib
  • Torin1
  • wortmannin
mTOR (human) tVPEsIHsFIGDGLV S2481-p
mTOR (mouse) tVPEsIHsFIGDGLV S2481-p
mTOR (rat) TVPEsIHsFIGDGLV S2481-p
K2489-ub
FIGDGLVkPEALNKk
0 1
mTOR (human) FIGDGLVkPEALNKk K2489-ub
mTOR (mouse) FIGDGLVKPEALNKk K2489
mTOR (rat) FIGDGLVKPEALNKK K2489
K2496-ub
kPEALNKkAIQIINR
0 2
mTOR (human) kPEALNKkAIQIINR K2496-ub
mTOR (mouse) KPEALNKkAIQIINR K2496-ub
mTOR (rat) KPEALNKKAIQIINR K2496